Drug Target Review Vaccine Development ebook 2021
Posted: 22 September 2021 | Drug Target Review | No comments yet
Within this ebook, find articles examining the role of telomerase for universal cancer vaccines and discussing potential targets for neurodegenerative disease vaccines.
In our first article, Dr Jens Bjørheim explains why vaccination could be the most effective strategy to target human telomerase when designing approaches to combat cancer. He also explores why vaccines with check-point inhibitors could also represent the next generation of antitelomerase therapeutics.
In our second piece, Dr Andrea Pfeifer evaluates the use of vaccines to tackle increasing rates of dementia. She explains that targeting the pathology of neurodegenerative diseases could halt a rise in the number of patients with dementia by utilising preventative precision medicine techniques.
Included in this ebook:
Drug Target Review has just announced the launch of its NEW and EXCLUSIVE report examining the evolution of AI and informatics in drug discovery and development.
In this 63 page in-depth report, experts and researchers explore the key benefits of AI and informatics processes, reveal where the challenges lie for the implementation of AI and how they see the use of these technologies streamlining workflows in the future.
Also featured are exclusive interviews with leading scientists from AstraZeneca, Auransa, PolarisQB and Chalmers University of Technology.
- Telomerase – a universal cancer target for immunotherapeutic vaccines
Dr Jens Bjørheim, Ultimovacs - An integrated vaccination approach to neurodegeneration
Dr Andrea Pfeifer, AC Immune
Related topics
Immunology, Molecular Biology, Molecular Targets, Neurosciences, Oncology, Vaccine
Related people
Dr Andrea Pfeifer (AC Immune), Dr Jens Bjørheim (Ultimovacs)
